Objective: To assess the suitability of nanocrystalline-coated silver dressings versus standard wound dressings in patients with type 2 diabetes after coronary revascularization.
Methods: The study involved 194 patients who were divided into two homogeneous groups. The control group (n = 97) received a standard sterile dressing.